Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SHE/301507 stock hub

SHE/301507 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301507is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301507

In the news

Latest news · SHE/301507

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E45

P25 23.5P50 41.3P75 83.2

ROE7

P25 -0.9P50 4.1P75 8.8

ROIC9.7

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301507 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

CNY

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	514
Enterprise value	CNY 4.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CNE1000068Q3
Last refreshed	2026-05-10
Market cap	CNY 5.3B
Price	CNY 14.87
Price currency	CNY
Rev Per Employee	1,610,214.01x
Sector	Healthcare
Sic	2834
Symbol	she/301507
Website	https://www.hzmsjk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.24%
EV Earnings	38.51x
EV/EBIT	45.13x
EV/EBITDA	34.51x
EV/FCF	-12,536.71x
EV/Sales	5.53x
FCF yield	-0.01%
P/B ratio	3x
P/E ratio	45.03x
P/S ratio	6.41x
PE Ratio3 Y	53.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.25%
EBITDA Margin	15.85%
Gross margin	52.03%
Gross Profit	CNY 430.6M
Gross Profit Growth	18.81%
Gross Profit Growth Q	20.53%
Gross Profit Growth3 Y	12.52%
Net Income	CNY 118.9M
Net Income Growth	24.25%
Net Income Growth Q	0.12%
Net Income Growth3 Y	5.03%
Pretax Margin	16.92%
Profit Margin	14.36%
Profit Per Employee	CNY 231,255
ROA	3.12
Roa5y	4.42
ROCE	5.63
ROE	6.97
Roe5y	10.14
ROIC	9.71
Roic5y	15.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.75%
EPS Growth	21.92
EPS Growth Q	0.17
EPS Growth3 Y	-5.38
FCF Growth Q	28.56%
OCF Growth	84.28%
OCF Growth Q	-4.6%
OCF Growth3 Y	-0.69%
Revenue Growth	22.06x
Revenue Growth Q	16.95x
Revenue Growth3 Y	11.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.41
Assets	CNY 2.1B
Cash	CNY 848.1M
Current Assets	CNY 1.1B
Current Liabilities	CNY 289.4M
Debt	CNY 3.4M
Debt EBITDA	CNY 0.03
Debt Equity	CNY 0
Debt FCF	CNY -9.22
Equity	CNY 1.8B
Liabilities	CNY 325M
Long Term Assets	CNY 981.8M
Long Term Liabilities	CNY 35.6M
Net Cash	CNY 844.7M
Net Cash By Market Cap	CNY 15.93
Net Cash Growth	-25.02%
Net Debt EBITDA	CNY -6.44
Net Debt Equity	CNY -0.48
Tangible Book Value	CNY 1.5B
Tangible Book Value Per Share	CNY 4.19
WACC	8.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.83
Inventory Turnover	6
Net Working Capital	CNY -27M
Quick ratio	3.15
Working Capital	CNY 819.3M
Working Capital Turnover	CNY 0.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.91%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.1
Dividend Years	2
Dividend Yield	0.67%
Ex Div Date	2025-06-20
Last Dividend	CNY 0.1
Payout Frequency	Annual
Payout Ratio	29.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.74%
200-day SMA	15.05
50-day SMA	14.5
50-day SMA vs 200-day SMA	50under200
All Time High	37.5
All Time High Change	-60.35%
All Time High Date	2023-09-05
All Time Low	10.28
All Time Low Change	44.65%
All Time Low Date	2024-02-06
ATR	0.34
Beta	0.7
Beta1y	0.25
Beta2y	0.27
Ch YTD	-3.19
High	14.92
High52	19.25
High52 Date	2025-11-14
High52ch	-22.75%
Low	14.7
Low52	13.06
Low52 Date	2025-05-12
Low52ch	13.86%
Ma50ch	2.59%
Price vs 200-day SMA	-1.18%
RSI	58.55
RSI Monthly	44.36
RSI Weekly	50.08
Sharpe ratio	0.66x
Sortino ratio	1.23
Total Return	-1.24%
Tr YTD	-3.19
Tr1m	4.79%
Tr1w	0.07%
Tr3m	-5.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 101.4M
Operating Income Growth	7.28
Operating Income Growth Q	13.71
Operating Income Growth3 Y	-0.66
Operating margin	12.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	110,531,858%
Shares Institutions	2.58%
Shares Out	356,554,330
Shares Qo Q	-2.98%
Shares Yo Y	1.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -365,156
Average Volume	3,372,670.95x
Bv Per Share	4.62
CAPEX	CNY -172.1M
Ch1m	4.79
Ch1w	0.07
Ch1y	12.91
Ch3m	-5.41
Ch6m	0.41
Change	0.95%
Change From Open	1.02
Close	14.73
Days Gap	-0.07
Depreciation Amortization	29,765,333
Dollar Volume	41,668,818.1
Earnings Date	2026-04-24
EBIT	CNY 101.4M
EBITDA	CNY 131.2M
EPS	CNY 0.33
F Score	5
FCF	CNY -365,156
FCF EV Yield	-0.01x
FCF Per Share	CNY -0
Financing CF	-89,645,843
Fiscal Year End	December
Founded	1,926
Goodwill	69,986,721
Graham Number	5.85707
Graham Upside	-60.61
Income Tax	CNY 18.8M
Investing CF	50,308,792
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Lynch Fair Value	CNY 1.66
Lynch Upside	-88.84
Ma150	15.05
Ma150ch	-1.21%
Ma20	14.4
Ma20ch	3.24%
Net CF	132,367,165
Next Earnings Date	2026-08-26
Open	14.72
P OCF Ratio	30.88
Payment Date	2025-06-20
Position In Range	77.27
Ppne	499,885,865
Price Date	2026-05-08
Price EBITDA	CNY 40.41
Ptbv Ratio	3.55
Relative Volume	0.83x
Revenue	827,650,002x
Tax By Revenue	2.27x
Tax Rate	13.39%
Tr6m	0.41%
Volume	2,802,207

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301507 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.10 annual per share

Payout ratio

+29.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-1.2%

Next ex-dividend date: 2025-06-20

Performance

SHE/301507 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301507?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.6%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.9%

Negative means the company is buying back shares.

Technical

SHE/301507 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.6

Neutral momentum band

Price vs 200-day MA

-1.2%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301507

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301507 stock rating?

she/301507 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301507 analysis?

The full report lives at /stocks/she/301507/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301507?

The latest report frames she/301507 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301507 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.